XML 13 R4.htm IDEA: XBRL DOCUMENT v3.19.3
Condensed Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Net sales $ 4,530,361 $ 4,651,358 $ 12,655,463 $ 13,357,013
Cost of goods sold 3,118,299 3,124,539 8,805,853 8,805,460
GROSS PROFIT 1,412,062 1,526,819 3,849,610 4,551,553
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES [1] 1,347,404 1,368,845 4,068,230 4,026,791
RESEARCH AND DEVELOPMENT EXPENSES [1] 218,467 179,915 667,774 490,463
(LOSS) INCOME FROM OPERATIONS (153,809) (21,941) (886,394) 34,299
INTEREST EXPENSE (22,799) (23,298) (67,589) (67,040)
OTHER INCOME 16,225 13,760 49,722 34,986
(LOSS) INCOME BEFORE INCOME TAXES (160,383) (31,479) (904,261) 2,245
INCOME TAX EXPENSE (BENEFIT) 2,361 (6,727) (170,775) 12,399
NET LOSS $ (162,744) $ (24,752) $ (733,486) $ (10,154)
LOSS PER COMMON SHARE        
Basic (in dollars per share) $ (0.08) $ (0.01) $ (0.37) $ (0.01)
Diluted (in dollars per share) $ (0.08) $ (0.01) $ (0.37) $ (0.01)
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING        
Weighted average common shares outstanding (in shares) 1,978,926 1,983,553 1,981,568 1,983,553
Diluted (in shares) 1,978,926 1,983,553 1,981,568 1,983,553
[1] The Company does not allocate all selling, general and administrative expenses or any research and development expenses to its operating segments for internal reporting.